Leerink Partnrs Issues Pessimistic Outlook for CSTL Earnings
Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) – Research analysts at Leerink Partnrs cut their Q2 2025 EPS estimates for shares of Castle Biosciences in a note issued to investors on Monday, May 5th. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings of ($0.44) per share for the quarter, down […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) – Research analysts at Leerink Partnrs cut their Q2 2025 EPS estimates for shares of Castle Biosciences in a note issued to investors on Monday, May 5th. Leerink Partnrs analyst P. Souda now anticipates that the company will post earnings of ($0.44) per share for the quarter, down […]
